Inhibition of myelopoiesis by serum from dogs exposed to estrogen

Am J Vet Res. 1993 Aug;54(8):1374-9.

Abstract

The mechanism of estrogen-induced myelotoxicosis is unknown, although evidence indicates that estrogen does not directly damage the bone marrow granulocyte-macrophage progenitor cells and that the thymus is a probable mediator of the bone marrow suppression. Estrogen-induced production of a myelopoiesis-inhibitory factor by canine thymic stromal cells in vitro has been observed. Then, presence of a myelopoiesis-inhibitory factor in canine serum was investigated immediately after estrogen administration in vivo. Maximal reduction in colony-forming units-granulocyte/macrophage growth by sera from individual dogs varied. Individual dog sensitivity to estrogen-induced myelotoxicosis is seen clinically, and the cause is unknown. This serum factor could have a role in the eventual bone marrow hypoplasia seen in estrogen-treated dogs and is possibly the same factor produced by cultured thymic stromal cells exposed to estrogen.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Marrow Diseases / blood
  • Bone Marrow Diseases / chemically induced
  • Bone Marrow Diseases / veterinary*
  • Colony-Forming Units Assay
  • Dog Diseases / blood*
  • Dog Diseases / chemically induced
  • Dogs
  • Erythrocyte Count / veterinary
  • Estradiol / analogs & derivatives*
  • Estradiol / toxicity
  • Female
  • Leukocyte Count / veterinary
  • Macrophages / drug effects
  • Male
  • Platelet Count / veterinary

Substances

  • Estradiol
  • estradiol 17 beta-cypionate